Paediatric patching not necessary

Article

Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

Early unilateral cataract surgery in infants can produce good visual outcomes even if patching is discontinued, according to a study in the August 2008 issue of the Archives of Ophthalmology.

Scott R. Lambert, MD of Emory Eye Center, Atlanta, US and colleagues conducted a medical record review of paediatric subjects (n=9) who had undergone surgery to treat unilateral congenital cataract at a mean age of 21.7 days. Subjects had remained patched for a mean 6.7 hours/day until at least 12 months of age, after which patching compliance declined to a mean of 1.7 hours/day by six years of age.

Four children abandoned patching entirely before their sixth birthdays: three maintained or increased visual acuity, whereas the fourth child lost two lines.

The researchers concluded that, if patients comply with the prescribed patching regime in early childhood, visual acuity can be maintained if patching is discontinued before the patient reaches six years of age.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.